ANGELS SANTE welcomes INITS as a new Corporate Member

June 2025 – Angels Santé, France’s leading network of healthcare-focused business angels, is pleased to welcome INITS as a new Corporate Member. This collaboration marks an additional step forward in fostering innovation and collaboration within the biotech ecosystem.

A Strategic Alliance to Accelerate Biotech Innovation

At the heart of this alliance lies a shared commitment to collaborative innovation. INITS will brings a wealth of experience in pharmaceutical development across the Angels Santé Biotech portfolio helping them anticipate and navigate key development challenges — ranging from CMC and Regulatory strategy to Clinical supply, Quality Assurance, and Audits.

Founded in 2013 and headquartered in Montpellier, INITS operates in France and internationally. The company is also developing a disruptive SMO (Shared Manufacturing Organization) concept, offering biotech companies a unique shared bioproduction facility. This unit will allow companies to manufacture their Drug Substances within a fully supervised space, supported by INITS’ expertise in Regulatory, Quality assurance, Quality control, Analytics, and Supply chain management.

"We are delighted to welcome INITS as a Corporate Member of Angels Santé. Their expertise will be a great asset for our biotech start-ups, saving valuable time and ensuring robust development strategies. We are particularly excited about the upcoming launch of the INITS SMO," said Eric Garnier, President of Angels Santé.

“Joining Angels Santé is a meaningful step for us. We look forward to actively contributing to this vibrant ecosystem and helping early-stage biotechs bring their innovations to patients faster and more efficiently,” added Amel Hadri, CEO of INITS.

About INITS

INITS is an innovative consulting company dedicated to supporting biotech companies in their pharmaceutical development journey.

Since 2013, we’ve supported more than 250 clients across Europe and internationally.

INITS operates through two divisions:

• INITS Consulting: We provide end-to-end support across all pharmaceutical development phases — in CMC, Regulatory strategy, Clinical supply, Quality Assurance, and Audits.

• INITS SMO: Currently in development and operational in Q2 2026, INITS SMO is a shared bioproduction facility that offers biotech companies a unique environment for Drug Substance manufacturing, with full support from INITS (Regulatory, QA, QC, Analytical, Supply Chain). For Drug Product manufacturing, INITS will act as a traditional CDMO, handling Fill & finish, Packaging, and product release operations.

Contact: t.urena@inits.fr

About Angels Santé

Angels Santé is France’s leading business angel network specializing in life sciences. With a diverse group of investors, we provide strategic support and funding to early-stage biotech, medtech and digital health companies, fostering innovation and growth in the healthcare sector.

Contact: info@angelssante.fr
Website: www.angelssante.fr